Clinical Trial Update: Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Early-stage clinical trial update evaluating Oncorine (H101) with tislelizumab and chemotherapy in untreated advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Oncorine (H101) (H101)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Untreated Advanced Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN